Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedNov 01, 2025
DataAggregated Company Financials
Companies15
  • 7D2.0%
  • 3M13.1%
  • 1Y12.9%
  • YTD16.3%

In the last week, the Pharma industry is up 2.0%, with GSK up 9.9%. This means that the industry has gained 13% over the past year. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 01 Nov 2025UK£302.8bUK£89.3bUK£13.9b20.7x21.7x3.4x
Mon, 29 Sep 2025UK£265.8bUK£87.8bUK£11.7b18.4x22.6x3x
Wed, 27 Aug 2025UK£281.7bUK£87.6bUK£11.7b21.7x24.1x3.2x
Fri, 25 Jul 2025UK£265.2bUK£86.4bUK£10.6b30.1x25x3.1x
Sun, 22 Jun 2025UK£259.3bUK£86.6bUK£10.6b25.9x24.4x3x
Tue, 20 May 2025UK£260.7bUK£86.9bUK£10.7b26.5x24.4x3x
Thu, 17 Apr 2025UK£254.7bUK£86.6bUK£9.6b26.9x26.5x2.9x
Sat, 15 Mar 2025UK£290.1bUK£87.7bUK£9.6b28.8x30.2x3.3x
Mon, 10 Feb 2025UK£280.9bUK£89.5bUK£9.5b30.1x29.4x3.1x
Wed, 08 Jan 2025UK£228.3bUK£75.6bUK£7.8b31.8x29.3x3x
Fri, 06 Dec 2024UK£226.8bUK£74.7bUK£7.7b32.1x29.5x3x
Sun, 03 Nov 2024UK£236.3bUK£72.6bUK£7.6b31.1x31.2x3.3x
Tue, 01 Oct 2024UK£249.2bUK£71.3bUK£8.9b30.4x27.9x3.5x
Thu, 29 Aug 2024UK£279.6bUK£71.9bUK£9.0b41.9x31.2x3.9x
Sat, 27 Jul 2024UK£259.8bUK£72.2bUK£9.6b34.8x27.2x3.6x
Mon, 24 Jun 2024UK£266.4bUK£71.7bUK£9.6b30.2x27.8x3.7x
Wed, 22 May 2024UK£271.2bUK£71.5bUK£9.6b33.9x28.3x3.8x
Fri, 19 Apr 2024UK£243.1bUK£71.4bUK£9.8b31.9x24.9x3.4x
Sun, 17 Mar 2024UK£236.0bUK£70.4bUK£9.7b32.3x24.3x3.4x
Tue, 13 Feb 2024UK£220.4bUK£69.7bUK£9.6b34.4x22.9x3.2x
Thu, 11 Jan 2024UK£244.6bUK£68.8bUK£10.7b36.5x22.9x3.6x
Sat, 09 Dec 2023UK£226.9bUK£69.4bUK£10.7b33.4x21.1x3.3x
Mon, 06 Nov 2023UK£229.8bUK£70.3bUK£11.0b53x20.9x3.3x
Wed, 04 Oct 2023UK£244.4bUK£70.9bUK£10.5b76.3x23.4x3.4x
Fri, 01 Sep 2023UK£236.3bUK£69.1bUK£10.2b53.5x23.2x3.4x
Sun, 30 Jul 2023UK£241.7bUK£68.1bUK£9.9b52.3x24.5x3.5x
Tue, 27 Jun 2023UK£245.7bUK£67.8bUK£7.9b55.5x31.2x3.6x
Thu, 25 May 2023UK£252.4bUK£68.8bUK£8.0b55.7x31.6x3.7x
Sat, 22 Apr 2023UK£262.0bUK£69.3bUK£6.9b63.2x38.2x3.8x
Mon, 20 Mar 2023UK£235.7bUK£70.1bUK£6.9b44.3x34x3.4x
Wed, 15 Feb 2023UK£251.2bUK£70.1bUK£7.4b40.9x34.2x3.6x
Fri, 13 Jan 2023UK£248.7bUK£79.8bUK£6.3b38.4x39.3x3.1x
Sun, 11 Dec 2022UK£247.0bUK£79.4bUK£6.3b36.1x39.2x3.1x
Tue, 08 Nov 2022UK£231.4bUK£81.3bUK£3.6b20.8x64.8x2.8x
Price to Earnings Ratio

64.8x


Total Market Cap: UK£231.4bTotal Earnings: UK£3.6bTotal Revenue: UK£81.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 28.4x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 21.7x which is lower than its 3-year average PE of 28.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 57% per year over the last three years.
  • Revenues for these companies have grown 3.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.62%
Healthcare1.81%
Pharma2.00%
Pharma2.00%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GSK GSKUK£17.819.9%
+UK£6.4b		25.4%PE13x
HLN HaleonUK£3.541.1%
+UK£329.5m		-4.9%PE20.7x
HIK Hikma PharmaceuticalsUK£18.394.9%
+UK£190.4m		-1.8%PE14.4x
AGY Allergy TherapeuticsUK£0.0865.5%
+UK£21.4m		57.3%PS7.4x
POLB Poolbeg PharmaUK£0.0376.3%
+UK£1.5m		-55.2%PB2.2x

Latest News

AZN
UK£124.70
AstraZeneca
7D
-0.5%
1Y
13.1%

AZN: In-Market Oncology And U.S. Drug Pricing Will Shape Long-Term Performance

AstraZeneca's analyst-derived fair value has been raised to $144.38 per share from $140.96. This reflects modest increases in pipeline confidence and anticipated revenue growth, as noted by analysts in recent research updates.
GSK
UK£17.81
GSK
7D
9.9%
1Y
25.4%

GSK: Technology Adoption And U.S. Investment Will Shape Sector Positioning Amid Policy Shifts

Analysts have raised their fair value estimate for GSK to $17.36 from $16.63. They cite higher profit margin expectations and improved sector sentiment following significant technology rollouts and favorable policy signals.
HLN
UK£3.54
Haleon
7D
1.1%
1Y
-4.9%
HIK
UK£18.39
Hikma Pharmaceuticals
7D
4.9%
1Y
-1.8%

Expanded US Market Access Will Drive Momentum Amid Regulatory Headwinds

Hikma Pharmaceuticals' analyst price target was slightly raised to £25.40 from £25.02, as analysts cite updated growth and profitability forecasts. This comes despite recent downward adjustments in individual firm targets.
NFX
UK£0.0038
Nuformix
7D
22.6%
1Y
560.9%
SAR
UK£0.14
Sareum Holdings
7D
-10.0%
1Y
-47.1%

We're Not Very Worried About Sareum Holdings' (LON:SAR) Cash Burn Rate

Oct 28
We're Not Very Worried About Sareum Holdings' (LON:SAR) Cash Burn Rate
ANCR
UK£2.51
Animalcare Group
7D
0.4%
1Y
5.5%
HCM
UK£2.20
HUTCHMED (China)
7D
-3.1%
1Y
-23.6%
STX
UK£0.067
Shield Therapeutics
7D
-8.9%
1Y
121.7%

Analysts Maintain Target for Shield Therapeutics Amid Positive Clinical News and Stable Valuation Metrics

Narrative Update on Shield Therapeutics: Analyst Price Target Revision Analysts have maintained their price target for Shield Therapeutics at £0.16. This reflects confidence in the company's prospects, given stable fair value estimates and consistent growth expectations.
FUM
UK£0.027
Futura Medical
7D
-6.8%
1Y
-92.8%

Investors Don't See Light At End Of Futura Medical plc's (LON:FUM) Tunnel And Push Stock Down 75%

Oct 18
Investors Don't See Light At End Of Futura Medical plc's (LON:FUM) Tunnel And Push Stock Down 75%
AGY
UK£0.086
Allergy Therapeutics
7D
5.5%
1Y
57.3%
INC
UK£0.022
Incanthera
7D
-40.0%
1Y
-84.5%
POLB
UK£0.037
Poolbeg Pharma
7D
6.3%
1Y
-55.2%